The Promise of Novel Therapies to Abolish Gluten Immunogenicity in Celiac Disease

被引：6

作者：

Cerf-Bensussan, Nadine ^{[1
]}

Schuppan, Detlef ^{[2
,3
]}

机构：

[1] Univ Paris, INSERM, Lab Intestinal Immun, Imagine Inst,Unite Mixte Rech 1163, Paris, France

[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Res Ctr Immune Therapy, Mainz, Germany

[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA

来源：

GASTROENTEROLOGY | 2021年 / 161卷 / 01期

关键词：

T-CELLS; DOUBLE-BLIND; TRIAL; IL-15;

D O I：

10.1053/j.gastro.2021.04.031

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：21 / 24

页数：4

共 24 条

[11] Interleukin 15 and CD4D+ T Cells Cooperate to Promote Small Intestinal Enteropathy in Response to Dietary Antigen [J].

Korneychuk, Natalia ;

Ramiro-Puig, Emma ;

Ettersperger, Julien ;

Schulthess, Julie ;

Montcuquet, Nicolas ;

Kiyono, Hiroshi ;

Meresse, Bertrand ;

Cerf-Bensussan, Nadine .

GASTROENTEROLOGY, 2014, 146 (04) :1017-1027

[12] Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study [J].

Lahdeaho, Marja-Leena ;

Scheinin, Mika ;

Vuotikka, Pekka ;

Taavela, Juha ;

Popp, Alina ;

Laukkarinen, Johanna ;

Koffert, Jukka ;

Koivurova, Olli-Pekka ;

Pesu, Marko ;

Kivela, Laura ;

Lovro, Zsofia ;

Keisala, Joni ;

Isola, Jorma ;

Parnes, Jane R. ;

Leon, Francisco ;

Maki, Markku .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (12) :948-959

[13] Coeliac disease [J].

Lebwohl, Benjamin ;

Sanders, David S. ;

Green, Peter H. R. .

LANCET, 2018, 391 (10115) :70-81

[14] Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial [J].

Leffler, Daniel A. ;

Kelly, Ciaran P. ;

Green, Peter H. R. ;

Fedorak, Richard N. ;

DiMarino, Anthony ;

Perrow, Wendy ;

Rasmussen, Henrik ;

Wang, Chao ;

Bercik, Premysl ;

Bachir, Natalie M. ;

Murray, Joseph A. .

GASTROENTEROLOGY, 2015, 148 (07) :1311-+

[15] Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles [J].

Pearson, Ryan M. ;

Podojil, Joseph R. ;

Shea, Lonnie D. ;

King, Nicholas J. C. ;

Miller, Stephen D. ;

Getts, Daniel R. .

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 18 :282-291

[16] Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium [J].

Pinier, Maud ;

Verdu, Elena F. ;

Nasser-Eddine, Mohamad ;

David, Chella S. ;

Vezina, Anne ;

Rivard, Nathalie ;

Leroux, Jean-Christophe .

GASTROENTEROLOGY, 2009, 136 (01) :288-298

[17] Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease [J].

Pultz, Ingrid Swanson ;

Hill, Malcolm ;

Vitanza, Joanne M. ;

Wolf, Clancey ;

Saaby, Lasse ;

Liu, Tina ;

Winkle, Peter ;

Leffler, Daniel A. .

GASTROENTEROLOGY, 2021, 161 (01) :81-+

[18] Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning [J].

Qiao, Shuo-Wang ;

Dahal-Koirala, Shiva ;

Eggesbo, Linn M. ;

Lundin, Knut E. A. ;

Sollid, Ludvig M. .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[19]

Ramsey N, 2021, PEDIAT ALLERG IMM-UK

[20] Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation [J].

Saito, Eiji ;

Kuo, Robert ;

Pearson, Ryan M. ;

Gohel, Nishant ;

Cheung, Brandon ;

King, Nicholas J. C. ;

Miller, Stephen D. ;

Shea, Lonnie D. .

JOURNAL OF CONTROLLED RELEASE, 2019, 300 :185-196

← 1 2 3 →